Clinical Trials Directory

Trials / Completed

CompletedNCT05188482

Using Vibroacoustic Therapy in a Patient With Co-infection and COVID-19

Complex Treatment Using Vibroacoustic Therapy in a Patient With Co-infection and COVID-19: Case Report.

Status
Completed
Phase
Study type
Observational
Enrollment
1 (actual)
Sponsor
Astana Medical University · Academic / Other
Sex
Male
Age
59 Years – 59 Years
Healthy volunteers

Summary

This article describes a case of successful treatment of a 59-year-old man with sepsis as a result of periprosthetic infection against the background of severe SARS-CoV-2-19, who was hospitalized for 59 days, 57 of which were in the intensive care unit. Vibroacoustic pulmonary therapy, the concept of noninvasive ventilation, syndrome therapy, combination antibiotic therapy taking into account the pathogen and antibiotic sensitivity were used in the treatment.

Detailed description

During the pandemic caused by SARS-CoV-2-19, the whole world faced difficulties. Nevertheless, surgeons had to perform surgical treatment for patients who needed immediate help with a confirmed coronavirus infection \[1, 2, 3\]. Periprosthetic joint infection is a severe and undesirable consequence after arthroplasty \[4, 5\]. Patients with coronavirus infection and bacterial infection correlate with an unfavorable outcome \[6, 7, 8\] The effect of vibroacoustic therapy in the treatment of various conditions has not been sufficiently studied \[9, 10\]. This clinical case describes the complex therapy of a patient with a periprosthetic infection on the background of SARS-CoV-2 using a vibroacoustic pulmonary device.

Conditions

Interventions

TypeNameDescription
DEVICEvibroacoustic therapyVibroacoustic respiratory therapy

Timeline

Start date
2020-09-29
Primary completion
2020-11-25
Completion
2021-01-01
First posted
2022-01-12
Last updated
2022-01-12

Locations

1 site across 1 country: Kazakhstan

Source: ClinicalTrials.gov record NCT05188482. Inclusion in this directory is not an endorsement.